VEGFA and age-related macular degeneration: Although bevacizumab is a humanized full-length monoclonal antibody against VEGF that binds to all VEGF isoforms, it was originally used for the treatment of colorectal tumors, and its use in AMD is considered an “over-the-counter” drug.